
BRO Stock Forecast & Price Target
BRO Analyst Ratings
Bulls say
Brown & Brown is supported by a durable brokerage model that benefits from exposure-unit expansion, disciplined M&A, and a decentralized sales-and-service culture that has historically driven organic growth above peers over time. Although near-term organic growth may be softer because of heightened competition in cat-exposed property and regulatory pressure in employee benefits, the company’s mix should help diversify results, cushion P&C-cycle volatility, and support more resilient total revenue, cash flow, and EPS growth even if 2026 organic growth trends toward the bottom-end of peers. Its operating profile also appears attractive, with shares cited at 12x 2027E EPS and 10x 2027E EV/EBITDA versus peer medians of 14x and 11x, while an expectation for a 34% EBITDAC margin versus a 29% peer median and Accession synergy progress on track reinforce a positive fundamental outlook despite $31M of talent-departure revenue loss and continued pricing pressure.
Bears say
Brown & Brown is facing a negative fundamental setup because the stock lacks a near-term catalyst for re-rating while macro headwinds and soft-market conditions are expected to limit organic growth and pressure margins, with downside risk in the cited scenario extending concerns into 2027. The bullish AI-disintermediation narrative appears overstated for Brown & Brown’s core commercial brokerage franchise, but that also means the shares are left dependent on ordinary operating performance rather than a disruptive growth reacceleration, especially as management and analysts point to only low-to-mid single-digit organic growth through 2027 and slightly lower margins versus 2025. Although total revenues are approaching $6 billion and strong cash flow conversion could support deleveraging and buybacks, the company has already lost $31 million in annualized revenue from employee departures to Howden, and any margin benefit from lower headcount is expected to fade as replacements are hired, leaving the name vulnerable to continued de-rating if growth does not inflect.
This aggregate rating is based on analysts' research of Brown & Brown and is not a guaranteed prediction by Public.com or investment advice.
BRO Analyst Forecast & Price Prediction
Start investing in BRO
Order type
Buy in
Order amount
Est. shares
0 shares